Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys

Area of Science:

• Virology
• Immunology
• Infectious Diseases

Background:

• Lassa fever is a severe hemorrhagic illness caused by the Lassa virus, an arenavirus.
• Effective vaccines are crucial for controlling Lassa fever outbreaks.
• Previous vaccination strategies have primarily focused on inducing humoral immunity.

Purpose of the Study:

• To evaluate the efficacy of a whole-inactivated Lassa virus vaccine in rhesus monkeys.
• To assess the immune response, including antibody production, following vaccination and challenge.
• To determine if vaccination confers protection against lethal Lassa virus infection.

Main Methods:

• Three rhesus monkeys were vaccinated with purified, gamma-irradiated, inactivated whole Lassa virus.
• Vaccinated and unvaccinated control monkeys were subsequently challenged with live Lassa virus.
• Humoral antibody responses were measured using radioimmunoprecipitation.
• Clinical signs, viral titers, and pathological changes were monitored.

Main Results:

• Vaccinated monkeys developed antibodies against major Lassa viral proteins.
• All vaccinated and control monkeys succumbed to severe Lassa fever following challenge.
• Vaccinated monkeys exhibited a secondary, high-titer antibody response, while controls showed a primary, low-titer response.
• Serum and organ viral loads at death did not significantly differ between groups.
• Clinical and biochemical parameters indicative of disease severity were comparable.

Conclusions:

• Humoral antibody response, even at levels seen in recovered humans, was insufficient to protect against lethal Lassa virus challenge in this model.
• Cell-mediated immunity may play a critical role in protection against arenavirus infections.
• Further research into vaccines that elicit a robust cell-mediated immune response is warranted for Lassa fever prevention.